$AEHR
AEHR TEST SYSTEMS

2021 Q4 Form 10-Q Financial Statement

#000165495422000518 Filed on January 14, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $9.611M $5.646M $1.683M
YoY Change 471.06% 180.62% -75.5%
Cost Of Revenue $5.092M $3.365M $1.306M
YoY Change 289.89% 88.52% -64.41%
Gross Profit $4.519M $2.281M $377.0K
YoY Change 1098.67% 904.85% -88.22%
Gross Profit Margin 47.02% 40.4% 22.4%
Selling, General & Admin $2.489M $1.953M $1.501M
YoY Change 65.82% 29.0% -30.51%
% of Gross Profit 55.08% 85.62% 398.14%
Research & Development $1.313M $1.321M $820.0K
YoY Change 60.12% 46.78% 2.5%
% of Gross Profit 29.06% 57.91% 217.51%
Depreciation & Amortization $76.00K $73.00K $90.00K
YoY Change -15.56% -8.75% 0.0%
% of Gross Profit 1.68% 3.2% 23.87%
Operating Expenses $3.802M $3.274M $2.321M
YoY Change 63.81% 35.63% -21.32%
Operating Profit $717.0K -$993.0K -$1.944M
YoY Change -136.88% -54.6% -877.6%
Interest Expense -$1.000K $9.000K -$10.00K
YoY Change -90.0% -30.77%
% of Operating Profit -0.14%
Other Income/Expense, Net $35.00K $23.00K -$6.000K
YoY Change -683.33% -124.47% -160.0%
Pretax Income $751.0K $719.0K -$1.962M
YoY Change -138.28% -765.74% -854.62%
Income Tax $34.00K -$23.00K $4.000K
% Of Pretax Income 4.53% -3.2%
Net Earnings $717.0K $696.0K -$1.966M
YoY Change -136.47% 550.47% -886.4%
Net Earnings / Revenue 7.46% 12.33% -116.82%
Basic Earnings Per Share $0.03 $0.03 -$0.08
Diluted Earnings Per Share $0.03 $0.03 -$0.08
COMMON SHARES
Basic Shares Outstanding 26.21M shares 24.00K shares 23.40M shares
Diluted Shares Outstanding 28.34M shares 25.36K shares 23.40M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.03M $6.530M $3.450M
YoY Change 915.39% 3.49% -34.91%
Cash & Equivalents $35.03M $6.530M $3.529M
Short-Term Investments
Other Short-Term Assets $622.0K $759.0K $430.0K
YoY Change 44.65% 72.5% -18.87%
Inventory $13.03M $10.15M $9.060M
Prepaid Expenses
Receivables $7.391M $4.264M $1.430M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $56.08M $21.70M $14.37M
YoY Change 290.24% 35.87% -31.15%
LONG-TERM ASSETS
Property, Plant & Equipment $661.0K $676.0K $2.600M
YoY Change -74.58% -73.7% -20.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $182.0K $189.0K $140.0K
YoY Change 30.0% 26.0% -26.32%
Total Long-Term Assets $2.108M $2.302M $2.740M
YoY Change -23.07% -15.37% -20.12%
TOTAL ASSETS
Total Short-Term Assets $56.08M $21.70M $14.37M
Total Long-Term Assets $2.108M $2.302M $2.740M
Total Assets $58.19M $24.00M $17.11M
YoY Change 240.06% 28.42% -29.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.386M $2.753M $1.160M
YoY Change 191.9% 239.88% -50.0%
Accrued Expenses $2.254M $1.978M $2.050M
YoY Change 9.95% -3.04% -7.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $1.210M
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $16.55M $8.760M $4.480M
YoY Change 269.31% 110.07% -29.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $470.0K
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $46.00K $46.00K $1.370M
YoY Change -96.64% -96.83% -31.16%
Total Long-Term Liabilities $46.00K $46.00K $1.840M
YoY Change -97.5% -97.91% -7.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.55M $8.760M $4.480M
Total Long-Term Liabilities $46.00K $46.00K $1.840M
Total Liabilities $17.32M $9.769M $6.320M
YoY Change 174.1% 53.36% -23.95%
SHAREHOLDERS EQUITY
Retained Earnings -$74.90M -$75.62M
YoY Change
Common Stock $115.9M $245.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.86M $14.23M $10.79M
YoY Change
Total Liabilities & Shareholders Equity $58.19M $24.00M $17.11M
YoY Change 240.06% 28.42% -29.59%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income $717.0K $696.0K -$1.966M
YoY Change -136.47% 550.47% -886.4%
Depreciation, Depletion And Amortization $76.00K $73.00K $90.00K
YoY Change -15.56% -8.75% 0.0%
Cash From Operating Activities $3.337M $1.874M -$2.900M
YoY Change -215.07% 191.45% 3122.22%
INVESTING ACTIVITIES
Capital Expenditures -$73.00K $59.00K -$140.0K
YoY Change -47.86% 25.53% 100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$73.00K -$59.00K -$140.0K
YoY Change -47.86% 25.53% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.24M $135.0K 180.0K
YoY Change 13921.67% -28.95% -21.74%
NET CHANGE
Cash From Operating Activities 3.337M $1.874M -2.900M
Cash From Investing Activities -73.00K -$59.00K -140.0K
Cash From Financing Activities 25.24M $135.0K 180.0K
Net Change In Cash 28.50M $1.948M -2.860M
YoY Change -1096.61% 121.36% -4185.71%
FREE CASH FLOW
Cash From Operating Activities $3.337M $1.874M -$2.900M
Capital Expenditures -$73.00K $59.00K -$140.0K
Free Cash Flow $3.410M $1.815M -$2.760M
YoY Change -223.55% 204.53% 13700.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26841819 shares
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
622000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35031000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4582000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7391000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5202000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
13033000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
8849000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
551000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
56077000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
19184000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
661000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
677000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1265000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1606000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
182000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
198000 USD
CY2021Q4 us-gaap Assets
Assets
58185000 USD
CY2021Q2 us-gaap Assets
Assets
21665000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3386000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2893000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2254000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2163000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
763000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
737000 USD
CY2021Q4 aehr Customer Deposits And Deferred Revenue Short Term
CustomerDepositsAndDeferredRevenueShortTerm
10142000 USD
CY2021Q2 aehr Customer Deposits And Deferred Revenue Short Term
CustomerDepositsAndDeferredRevenueShortTerm
189000 USD
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2021Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1400000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1679000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16545000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9061000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
616000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1007000 USD
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
116000 USD
CY2021Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
99000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
49000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
17323000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
10216000 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26835000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23725000 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
268000 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
237000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
115602000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
87553000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-108000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-28000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74900000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-76313000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
40862000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
11449000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58185000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21665000 USD
CY2021Q4 us-gaap Revenues
Revenues
9611000 USD
CY2020Q4 us-gaap Revenues
Revenues
1683000 USD
us-gaap Revenues
Revenues
15257000 USD
us-gaap Revenues
Revenues
3695000 USD
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
5092000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25000 USD
CY2021Q4 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2020Q4 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2186000 USD
CY2020Q4 us-gaap Cost Of Revenue
CostOfRevenue
1306000 USD
us-gaap Cost Of Revenue
CostOfRevenue
8457000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3015000 USD
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1313000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
820000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2634000 USD
us-gaap Cost Of Revenue
CostOfRevenue
3091000 USD
CY2021Q4 us-gaap Gross Profit
GrossProfit
4519000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
377000 USD
us-gaap Gross Profit
GrossProfit
6800000 USD
us-gaap Gross Profit
GrossProfit
604000 USD
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2489000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1501000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4442000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1720000 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
3802000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
2321000 USD
us-gaap Operating Expenses
OperatingExpenses
7076000 USD
us-gaap Operating Expenses
OperatingExpenses
4735000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
717000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1944000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-276000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4131000 USD
CY2021Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000 USD
CY2020Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
10000 USD
CY2021Q4 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 USD
CY2020Q4 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 USD
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
1698000 USD
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 USD
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
35000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
58000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
751000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1962000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1470000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2070000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-211000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
717000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-1966000 USD
us-gaap Net Income Loss
NetIncomeLoss
1413000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1859000 USD
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Net Income Loss
NetIncomeLoss
-1859000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26205000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23396000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25102000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23322000 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28342000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23396000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26849000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23322000 shares
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
717000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-1966000 USD
us-gaap Net Income Loss
NetIncomeLoss
1413000 USD
CY2021Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-44000 USD
CY2020Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
5000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-80000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
104000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
0 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
2401000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
673000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1961000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1333000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4156000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
21000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
673000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1961000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1333000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4177000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
14232000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1209000 USD
CY2021Q4 aehr Proceeds From Public Offerings Net Of Issuance Costs Amount
ProceedsFromPublicOfferingsNetOfIssuanceCostsAmount
24030000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
718000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
717000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-44000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
40862000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
11449000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2744000 USD
aehr Proceeds From Public Offerings Net Of Issuance Costs Amount
ProceedsFromPublicOfferingsNetOfIssuanceCostsAmount
24030000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1306000 USD
us-gaap Net Income Loss
NetIncomeLoss
1413000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-80000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
40862000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
12321000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
175000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
257000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-1966000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
10792000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
14056000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
365000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1306000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
527000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
149000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
165000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2186000 USD
aehr Income Tax Benefit Related To Dissolution Of Subsidiary
IncomeTaxBenefitRelatedToDissolutionOfSubsidiary
0 USD
aehr Income Tax Benefit Related To Dissolution Of Subsidiary
IncomeTaxBenefitRelatedToDissolutionOfSubsidiary
-215000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
527000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1859000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
104000 USD
aehr Reclassification Of Cumulative Translation Adjustment As A Result Of Dissolution Of Aehr Test Systems Japan
ReclassificationOfCumulativeTranslationAdjustmentAsAResultOfDissolutionOfAehrTestSystemsJapan
-2401000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
10792000 USD
us-gaap Net Income Loss
NetIncomeLoss
1413000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1859000 USD
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
1698000 USD
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2284000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2341000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4212000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1067000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-60000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
92000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
512000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
160000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
104000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-97000 USD
aehr Increase Decrease In Customer Deposits And Deferred Revenue
IncreaseDecreaseInCustomerDepositsAndDeferredRevenue
9970000 USD
aehr Increase Decrease In Customer Deposits And Deferred Revenue
IncreaseDecreaseInCustomerDepositsAndDeferredRevenue
-117000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
11000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5211000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2255000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
132000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
194000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-132000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-194000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1400000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2744000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
365000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
24030000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25374000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
365000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-4000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
100000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30449000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1984000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4662000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5513000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35111000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3529000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
19000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15257000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3695000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9611000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1683000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15257000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3695000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
10258000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
288000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
140000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
239000 USD
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.23 pure
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.77 pure
CY2021Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
30582000 USD
CY2021Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
580000 USD
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
80000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1453000 USD
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4857000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2988000 USD
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
13033000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
8849000 USD
us-gaap Standard Product Warranty Description
StandardProductWarrantyDescription
The standard warranty period is one year for systems and ninety days for parts and service
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
494000 USD
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
246000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
257000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
192000 USD
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
72000 USD
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
87000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
408000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
281000 USD
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
415000 USD
CY2021Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1696729 shares
CY2021Q2 us-gaap Customer Deposits Current
CustomerDepositsCurrent
27000 USD
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
133000 USD
CY2021Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
162000 USD
CY2021Q2 aehr Customer Deposits And Deferred Revenue
CustomerDepositsAndDeferredRevenue
189000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0543 pure
us-gaap Operating Lease Cost
OperatingLeaseCost
385000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
375000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
408000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
382000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
406000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
829000 USD
CY2021Q4 aehr Sale Of Stock Average Price Per Share
SaleOfStockAveragePricePerShare
14.73
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">ACCOUNTING ESTIMATES. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used to account for sales and revenue allowances, the allowance for doubtful accounts, inventory valuations, income taxes, stock-based compensation expenses, and product warranties, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances. Actual results could differ materially from those estimates.</p>
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9611000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1683000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15257000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3695000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9611000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1683000 USD
CY2021Q4 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
72000 USD
CY2020Q4 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
11000 USD
CY2021Q4 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
257000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1379000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1306000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
527000 USD
CY2021Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
31000 USD
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8169000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5859000 USD
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
505000 USD
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
330000 USD
CY2021Q4 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
95000 USD
CY2020Q4 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
113000 USD
CY2020Q4 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
210000 USD
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
244000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
11035000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
95000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y2M19D
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
40000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.98
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
237000 shares
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
4129000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.86
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
155000 shares
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
256000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
661000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
677000 USD
CY2021Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
10009000 USD
CY2021Q4 aehr Customer Deposits And Deferred Revenue
CustomerDepositsAndDeferredRevenue
10142000 USD
CY2021Q4 aehr Provision For Income Tax
ProvisionForIncomeTax
34000 USD
aehr Provision For Income Tax
ProvisionForIncomeTax
56000 USD
CY2020Q4 aehr Provision For Income Tax
ProvisionForIncomeTax
4000 USD
aehr Provision For Income Tax
ProvisionForIncomeTax
215000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2021Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
192000 USD
CY2020Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
190000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
168000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
31000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
74000 USD
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
718000 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
257000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9133000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y11M4D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
24.57
aehr Rsus Granted For Bonus
RsusGrantedForBonus
49000 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
120000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
11000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
14000 shares
CY2021Q4 aehr Commission Fee Related To The Atm Offering
CommissionFeeRelatedToTheAtmOffering
700000 USD
CY2021Q4 aehr Offering Expense Related To The Atm Offering
OfferingExpenseRelatedToTheAtmOffering
300000 USD

Files In Submission

Name View Source Status
0001654954-22-000518-index-headers.html Edgar Link pending
0001654954-22-000518-index.html Edgar Link pending
0001654954-22-000518.txt Edgar Link pending
0001654954-22-000518-xbrl.zip Edgar Link pending
aehr-20211130.xsd Edgar Link pending
aehr-20211130_cal.xml Edgar Link unprocessable
aehr-20211130_def.xml Edgar Link unprocessable
aehr-20211130_lab.xml Edgar Link unprocessable
aehr-20211130_pre.xml Edgar Link unprocessable
aehr_10q.htm Edgar Link pending
aehr_10q_htm.xml Edgar Link completed
aehr_ex311.htm Edgar Link pending
aehr_ex312.htm Edgar Link pending
aehr_ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending